Benchmarking antimicrobial drug use in hospitals
Surveillance of antibiotic use in hospitals: methods, trends and targets
In the United States, the recommended metric for aggregate antibiotic use is days of therapy/1000 patient-days.
Clinical outcomes, including response to therapy and bacterial resistance, are critical measures but are more difficult to document than economic outcomes..
[PDF] The Core Elements of Hospital Antibiotic Stewardship Programs - CDC
In the United States, the recommended metric for aggregate antibiotic use is days of therapy/1000 patient-days.
Clinical outcomes, including response to therapy and bacterial resistance, are critical measures but are more difficult to document than economic outcomes..
[PDF] The Core Elements of Hospital Antibiotic Stewardship Programs - CDC
The results highlight significant growth in consumption over time, with the global antibiotic consumption rate rising from 9.8 to 14.
3) DDDs per 1,000 population per day between 2000 and 2018, an increase of 46 percent..
Measuring and monitoring antibiotic use in hospitals is believed to be an important component of the strategies available to antimicrobial stewardship programs to address acquired antimicrobial resistance.
The purpose of this review is to describe recent methods to benchmark antimicrobial drug use and to critically assess the potential advantages and the remaining
Antibiotic Use and Stewardship Data for Action
Tracking and reporting data on antibiotic use helps identify where healthcare settings need stewardship interventions most.
CDC also tracks antibiotic stewardship by assessing the uptake of the Core Elements of Antibiotic Stewardship.
CDC shares these data and updates yearly on the Antibiotic Resistance & Patient Safety Portal.
Are there complete definitions of antibiotic use measurements?
The literature review revealed underreporting of complete definitions of antibiotic use measurements.
Data on in-hospital antimicrobial use vary widely not only due to different antibiotic policies at different institutions but also due to different methods of measures.
Be Antibiotics Aware Campaign Updates/Accomplishments
In November and December 2022, Be Antibiotics Aware advertisements during U.S.
Antibiotic Awareness Week generated more than 14 million impressions and 1 million link clicks to the CDC website.
Webpage views almost doubled from 26 million+ views in June 2022 to 45 million+ views in June 2023, a 73% increase.
As of June 2023, the partner toolkit has.
Does health equity influence antibiotic prescribing rates and appropriateness?
The review revealed several gaps in knowledge and found that antibiotic prescribing rates and appropriateness varied by patient and clinician factors, such as:
patient race and insurance status and clinician type.
These findings emphasize the importance of integrating health equity into antibiotic stewardship policies, practices, and research. Findings from CDC Studies
Several studies supported by CDC’s Office of Antibiotic Stewardship assessed variation in antibiotic prescribing in different healthcare settings and populations, and highlighted opportunities and implementation strategies to improve antibiotic use.
Introduction
Antibiotic stewardship is the effort to optimize how antibiotics are used and is a core strategy to combat antimicrobial resistance.
In 2023, the Office of Antibiotic Stewardship at the Centers for Disease Control and Prevention (CDC) issued new and updated guidance and resources to support the implementation of antimicrobial and diagnostic stewardship across the spectrum of health care.
CDC continues to track antimicrobial use and stewardship implementation data across human healthcare settings to evaluate progress and ensure equitable access to high quality health care.
NEW Antibiotic Stewardship Guidance
Leveraging Health Systems to Expand and Enhance Antibiotic Stewardship in Outpatient Settings
New Online Resources
Be Antibiotics Aware / Get Ahead of Sepsis
What is the advancing health equity through antimicrobial stewardship workshop?
The “ Advancing Health Equity through Antimicrobial Stewardship workshop ” is a healthcare professional educational program developed by the Society for Healthcare Epidemiology (SHEA) to identify and address health inequities as they relate to antibiotic stewardship and antimicrobial resistance.
Why do data on in-hospital antimicrobial use vary widely?
Data on in-hospital antimicrobial use vary widely not only due to different antibiotic policies at different institutions but also due to different methods of measures.
Adherence to the standard of reporting the methods of measurement is warranted for benchmarking and promotion of rational antimicrobial use.
Antimicrobial stewardship is the systematic effort to educate and persuade prescribers of antimicrobials to follow evidence-based prescribing, in order to stem antimicrobial overuse, and thus antimicrobial resistance.
AMS has been an organized effort of specialists in infectious diseases, both in Internal Medicine and Pediatrics with their respective peer-organizations, hospital pharmacists, the public health community and their professional organizations since the late 1990s.
It has first been implemented in hospitals.
In the U.S., within the context of physicians' prescribing freedom, AMS had largely been voluntary self-regulation in the form of policies and appeals to adhere to a prescribing self-discipline until 2017, when the Joint Commission prescribed that hospitals should have an Antimicrobial Stewardship team, which was expanded to the outpatient setting in 2020.
Antimicrobial stewardship is the systematic effort to educate and persuade prescribers of antimicrobials to follow evidence-based prescribing, in order to stem antimicrobial overuse, and thus antimicrobial resistance.
AMS has been an organized effort of specialists in infectious diseases, both in Internal Medicine and Pediatrics with their respective peer-organizations, hospital pharmacists, the public health community and their professional organizations since the late 1990s.
It has first been implemented in hospitals.
In the U.S., within the context of physicians' prescribing freedom, AMS had largely been voluntary self-regulation in the form of policies and appeals to adhere to a prescribing self-discipline until 2017, when the Joint Commission prescribed that hospitals should have an Antimicrobial Stewardship team, which was expanded to the outpatient setting in 2020.
